Use of transgenic and mutant animal models in the study of heterocyclic amine-induced mutagenesis and carcinogenesis |
| |
Authors: | Dashwood Roderick H |
| |
Institution: | Department of Environmental & Molecular Toxicology, and Linus Pauling Institute, Oregon State University, Corvallis, OR 97331-6512, USA. Rod.Dashwood@oregonstate.edu |
| |
Abstract: | Heterocyclic amines (HCAs) are potent mutagens generated during the cooking of meat and fish, and several of these compounds produce tumors in conventional experimental animals. During the past 5 years or so, HCAs have been tested in a number of novel in vivo murine models, including the following: lacZ, lacI, cII, c-myc/lacZ, rpsL, and gptDelta. transgenics, XPA-/-, XPC-/-, Msh2+/-, Msh2-/- and p53+/- knock-outs, Apc mutant mice (ApcDelta716, Apc1638N, Apcmin), and A33DeltaNbeta-cat knock-in mice. Several of these models have provided insights into the mutation spectra induced in vivo by HCAs in target and non-target organs for tumorigenesis, as well as demonstrating enhanced susceptibility to HCA-induced tumors and preneoplastic lesions. This review describes several of the more recent reports in which novel animal models were used to examine HCA-induced mutagenesis and carcinogenesis in vivo, including a number of studies which assessed the inhibitory activities of chemopreventive agents such as 1,2-dithiole-3-thione, conjugated linoleic acids, tea, curcumin, chlorophyllin-chitosan, and sulindac. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|